SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-014247
Filing Date
2023-04-25
Accepted
2023-04-25 08:00:41
Documents
21

Document Format Files

Seq Description Document Type Size
1 DEF 14A omga-20230424.htm   iXBRL DEF 14A 930461
2 GRAPHIC img112197562_0.jpg GRAPHIC 2584
3 GRAPHIC img112197562_1.jpg GRAPHIC 10418
4 GRAPHIC img112197562_2.jpg GRAPHIC 11697
5 GRAPHIC img112197562_3.jpg GRAPHIC 10418
6 GRAPHIC img112197562_4.jpg GRAPHIC 23775
7 GRAPHIC img112197562_5.jpg GRAPHIC 23775
8 GRAPHIC img112197562_6.jpg GRAPHIC 11697
9 GRAPHIC img112197562_7.jpg GRAPHIC 76836
10 GRAPHIC img112197562_8.jpg GRAPHIC 78261
  Complete submission text file 0000950170-23-014247.txt   1668560

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT omga-20230424_lab.xml EX-101.LAB 3164
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT omga-20230424_pre.xml EX-101.PRE 2776
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT omga-20230424.xsd EX-101.SCH 2479
15 EXTRACTED XBRL INSTANCE DOCUMENT omga-20230424_htm.xml XML 1301
Mailing Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140 (617) 949-4360
Omega Therapeutics, Inc. (Filer) CIK: 0001850838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40657 | Film No.: 23841801
SIC: 2836 Biological Products, (No Diagnostic Substances)